GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Developments PLC (AQSE:ANA) » Definitions » EBITDA Margin %

Ananda Developments (AQSE:ANA) EBITDA Margin % : 0.00% (As of Jul. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Ananda Developments EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Ananda Developments's EBITDA for the six months ended in Jul. 2023 was £-0.84 Mil. Ananda Developments's Revenue for the six months ended in Jul. 2023 was £0.00 Mil. Therefore, Ananda Developments's EBITDA margin for the quarter that ended in Jul. 2023 was 0.00%.


Ananda Developments EBITDA Margin % Historical Data

The historical data trend for Ananda Developments's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ananda Developments EBITDA Margin % Chart

Ananda Developments Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23
EBITDA Margin %
- - - - -

Ananda Developments Semi-Annual Data
Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Ananda Developments's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Ananda Developments's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ananda Developments's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ananda Developments's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Ananda Developments's EBITDA Margin % falls into.



Ananda Developments EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Ananda Developments's EBITDA Margin % for the fiscal year that ended in Jan. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Jan. 2023 )/Revenue (A: Jan. 2023 )
=-0.881/0
= %

Ananda Developments's EBITDA Margin % for the quarter that ended in Jul. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Jul. 2023 )/Revenue (Q: Jul. 2023 )
=-0.844/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ananda Developments  (AQSE:ANA) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Ananda Developments EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Ananda Developments's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ananda Developments (AQSE:ANA) Business Description

Traded in Other Exchanges
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Ananda Developments PLC provides investment to healthcare market for the companies that develop medicinal or therapeutic cannabis derivatives, or related products including nutraceuticals, dietary supplements, and cosmetic products which contain Cannabis or hemp derived cannabinoids.

Ananda Developments (AQSE:ANA) Headlines

No Headlines